Skip to content

Clinical trials

Phase 1 Multiple Sclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 1 Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20101
20131
20152
20161
20172
20181
20191
20213
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Contineum Therapeutics2
East Kent Hospitals University NHS Foundation Trust2
GlaxoSmithKline2
AbbVie1
Abide Therapeutics1
Apitope Technology (Bristol) Ltd.1
AstraZeneca1
Autolus Limited1
Biogen1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis18
Multiple Sclerosis, Chronic Progressive3
Multiple Sclerosis, Relapsing-Remitting3
Demyelinating Diseases2
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Colitis, Ulcerative1
Demyelinating Autoimmune Diseases, CNS1
Idiopathic Pulmonary Fibrosis1
Immune System Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.